GB201509782D0 - Methods and products for fusion protein synthesis - Google Patents

Methods and products for fusion protein synthesis

Info

Publication number
GB201509782D0
GB201509782D0 GBGB1509782.7A GB201509782A GB201509782D0 GB 201509782 D0 GB201509782 D0 GB 201509782D0 GB 201509782 A GB201509782 A GB 201509782A GB 201509782 D0 GB201509782 D0 GB 201509782D0
Authority
GB
United Kingdom
Prior art keywords
products
methods
fusion protein
protein synthesis
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1509782.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1509782.7A priority Critical patent/GB201509782D0/en
Publication of GB201509782D0 publication Critical patent/GB201509782D0/en
Priority to KR1020187000488A priority patent/KR102818627B1/ko
Priority to EP16728359.7A priority patent/EP3303374B1/en
Priority to DK16728359.7T priority patent/DK3303374T3/da
Priority to CA2987821A priority patent/CA2987821C/en
Priority to CN202211548024.1A priority patent/CN116199733A/zh
Priority to PCT/GB2016/051640 priority patent/WO2016193746A1/en
Priority to US15/578,486 priority patent/US10526379B2/en
Priority to BR112017026042-5A priority patent/BR112017026042B1/pt
Priority to AU2016272543A priority patent/AU2016272543B2/en
Priority to CN201680037511.8A priority patent/CN108026148B/zh
Priority to JP2017563189A priority patent/JP6883529B2/ja
Priority to ES16728359T priority patent/ES2880336T3/es
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/90Fusion polypeptide containing a motif for post-translational modification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB1509782.7A 2015-06-05 2015-06-05 Methods and products for fusion protein synthesis Ceased GB201509782D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1509782.7A GB201509782D0 (en) 2015-06-05 2015-06-05 Methods and products for fusion protein synthesis
ES16728359T ES2880336T3 (es) 2015-06-05 2016-06-03 Métodos y productos para la síntesis de proteínas de fusión
PCT/GB2016/051640 WO2016193746A1 (en) 2015-06-05 2016-06-03 Methods and products for fusion protein synthesis
EP16728359.7A EP3303374B1 (en) 2015-06-05 2016-06-03 Methods and products for fusion protein synthesis
DK16728359.7T DK3303374T3 (da) 2015-06-05 2016-06-03 FREMGANGSMÅDER OG PRODUKTER til FUSIONSPROTEINSYNTESE
CA2987821A CA2987821C (en) 2015-06-05 2016-06-03 Methods and products for fusion protein synthesis
CN202211548024.1A CN116199733A (zh) 2015-06-05 2016-06-03 融合蛋白合成的方法和产品
KR1020187000488A KR102818627B1 (ko) 2015-06-05 2016-06-03 융합 단백질 합성용 방법 및 생성물
US15/578,486 US10526379B2 (en) 2015-06-05 2016-06-03 Methods and products for fusion protein synthesis
BR112017026042-5A BR112017026042B1 (pt) 2015-06-05 2016-06-03 Proteína de fusão e seu método de produção, ligante de peptídeo, par de ligantes de peptídeo e uso dos mesmos, polipeptídeo recombinante ou sintético, molécula de ácido nucleico, vetor, célula hospedeira recombinante e kit
AU2016272543A AU2016272543B2 (en) 2015-06-05 2016-06-03 Methods and products for fusion protein synthesis
CN201680037511.8A CN108026148B (zh) 2015-06-05 2016-06-03 融合蛋白合成的方法和产品
JP2017563189A JP6883529B2 (ja) 2015-06-05 2016-06-03 融合タンパク質を合成するための方法および製品

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1509782.7A GB201509782D0 (en) 2015-06-05 2015-06-05 Methods and products for fusion protein synthesis

Publications (1)

Publication Number Publication Date
GB201509782D0 true GB201509782D0 (en) 2015-07-22

Family

ID=53785013

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1509782.7A Ceased GB201509782D0 (en) 2015-06-05 2015-06-05 Methods and products for fusion protein synthesis

Country Status (10)

Country Link
US (1) US10526379B2 (enExample)
EP (1) EP3303374B1 (enExample)
JP (1) JP6883529B2 (enExample)
KR (1) KR102818627B1 (enExample)
CN (2) CN116199733A (enExample)
AU (1) AU2016272543B2 (enExample)
DK (1) DK3303374T3 (enExample)
ES (1) ES2880336T3 (enExample)
GB (1) GB201509782D0 (enExample)
WO (1) WO2016193746A1 (enExample)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10526376B2 (en) 2015-01-15 2020-01-07 University Of Copenhagen Virus-like particle with efficient epitope display
GB201509782D0 (en) * 2015-06-05 2015-07-22 Isis Innovation Methods and products for fusion protein synthesis
DK3368068T3 (da) 2015-10-30 2021-02-22 Univ Copenhagen Viruslignende partikler med effektiv epitopdisplay
WO2018170362A2 (en) * 2017-03-16 2018-09-20 The Penn State Research Foundation Versatile display scaffolds for proteins
GB201705750D0 (en) * 2017-04-10 2017-05-24 Univ Oxford Innovation Ltd Peptide ligase and use therof
GB201706430D0 (en) 2017-04-24 2017-06-07 Univ Oxford Innovation Ltd Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof
CN107299107A (zh) * 2017-07-31 2017-10-27 北京大学 一种蛋白质层层组装功能材料的制备方法
EP4524157A3 (en) 2017-10-25 2025-06-18 Abera Bioscience AB Omv display
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
JP7575096B2 (ja) 2018-05-04 2024-10-29 スパイバイオテック・リミテッド ワクチン組成物
US12360021B2 (en) 2018-08-20 2025-07-15 The Regents Of The University Of California Graphene oxide affinity sample grids for Cyro-EM
CN111073925B (zh) * 2018-10-19 2022-04-26 北京大学 一种基于无序蛋白偶联酶的高效多肽-多肽偶联系统和方法
GB201819850D0 (en) 2018-12-05 2019-01-23 Univ Oxford Innovation Ltd Polypeptide and its use in affinity purification
GB201903479D0 (en) 2019-03-14 2019-05-01 Univ Oxford Innovation Ltd Polypeptide with enchanced rate of spontaneous isopeptide bond formation with it's peptide tag partner and uses thereof
WO2020188346A1 (en) 2019-03-18 2020-09-24 Bio-Rad Abd Serotec Gmbh Antigen binding proteins
AU2020243436A1 (en) 2019-03-18 2021-10-07 Bio-Rad Abd Serotec Gmbh Antigen binding fragments conjugated to a plurality of Fc isotypes and subclasses
WO2020188350A1 (en) 2019-03-18 2020-09-24 Bio-Rad Abd Serotec Gmbh Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation
US12163164B2 (en) 2019-07-15 2024-12-10 Bio-Rad Laboratories, Inc. Hybrid reverse transcriptases
NL2023863B1 (en) 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
CN112646800B (zh) * 2019-10-11 2025-10-17 北京科技大学 制备固定化酶或固定化蛋白质的方法以及固定化酶或固定化蛋白质
GB201915905D0 (en) 2019-11-01 2019-12-18 Spybiotech Ltd Viruses with modified capsid proteins
EP3831843A1 (en) 2019-12-08 2021-06-09 Royal College Of Surgeons In Ireland A hemostatic agent and uses thereof
EP4135665A2 (en) * 2020-04-13 2023-02-22 Mantra Bio, Inc. Modular binding proteins for extracellular vesicles and uses thereof
AU2021268757A1 (en) * 2020-05-07 2022-12-08 Adaptvac Aps Peptide tags and binding partners
EP4176262B1 (en) * 2020-07-02 2025-06-25 King Abdullah University Of Science And Technology Nanobody functionalized electrochemical transistors and methods of making and using thereof
US12298314B2 (en) 2020-10-09 2025-05-13 10X Genomics, Inc. Methods and compositions for analyzing target binding of molecules
WO2022076914A1 (en) 2020-10-09 2022-04-14 10X Genomics, Inc. Methods and compositions for profiling immune repertoire
GB202019817D0 (en) 2020-12-15 2021-01-27 Univ Oxford Innovation Ltd Ligand-binding polypeptides and uses thereof
GB202104104D0 (en) * 2021-03-24 2021-05-05 Liliumx Ltd Platform and method
GB202104999D0 (en) * 2021-04-08 2021-05-26 Univ Oxford Innovation Ltd Polypeptides that interact with peptide tags at loops or termini and uses thereof
CN113621031B (zh) * 2021-04-23 2023-05-05 中山大学 一种利用自发异肽键进行蛋白共价自组装的肽链接头的组合
WO2022234276A1 (en) 2021-05-04 2022-11-10 SpyBiotech Limited Adenoviral vectors and vaccines thereof
GB202106361D0 (en) 2021-05-04 2021-06-16 Spybiotech Ltd Viral vectored vaccines
US20250129132A1 (en) * 2021-09-21 2025-04-24 University Of Washington Genetically encoded and exogenously triggered protein-protein ligation
CN113862235B (zh) * 2021-09-24 2024-07-05 苏州近岸蛋白质科技股份有限公司 一种嵌合酶及其在体外一步反应合成Cap0 mRNA的用途和方法
GB202117283D0 (en) 2021-11-30 2022-01-12 Univ Oxford Innovation Ltd Switchable polypeptide and its use for gentle affinity purification
WO2023102156A1 (en) 2021-12-03 2023-06-08 Wisconsin Alumni Research Foundation Mutant ace2 proteins and methods of using same
EP4206674B1 (en) 2021-12-28 2025-10-22 Encodia, Inc. High-throughput serotyping and antibody profiling assays
CN114672505A (zh) * 2022-03-15 2022-06-28 江苏省中国科学院植物研究所 一种功能性表达细胞色素p450酶的方法及其应用
CN114732898B (zh) * 2022-04-01 2023-05-09 中国人民解放军军事科学院军事医学研究院 一种CpG佐剂与抗原定点共价结合方法
US20260077032A1 (en) * 2022-06-30 2026-03-19 La Jolla Institute For Immunology KARI Nanoparticle
CN116284278B (zh) * 2022-07-22 2025-10-03 南京工业大学 一种高酯键形成效率分子肽突变体
EP4590626A2 (en) * 2022-09-19 2025-07-30 The Rockefeller University Affinity capturing and directly determining structures of proteins and other materials on superparamagnetic beads by cryo-electron microscopy single-particle analysis
US20260036590A1 (en) 2022-09-28 2026-02-05 Valink Therapeutics Ltd Multivalent proteins and screening methods
CN116047055A (zh) * 2022-11-18 2023-05-02 常州伯仪生物科技有限公司 一种大规模定向标记碱性磷酸酶的方法
CN116165377A (zh) * 2023-04-21 2023-05-26 常州伯仪生物科技有限公司 一种通过竞争elisa法进行标签蛋白定量的方法
GB202306808D0 (en) 2023-05-09 2023-06-21 Univ Oxford Innovation Ltd Method for detecting interactions
GB202313175D0 (en) 2023-08-30 2023-10-11 Univ Oxford Innovation Ltd A bivalent polypeptide scaffold and uses thereof
US20250122482A1 (en) 2023-09-07 2025-04-17 Regeneron Pharmaceuticals, Inc. Production and purification of covalently surface modified adeno-associated virus
GB202315107D0 (en) 2023-10-02 2023-11-15 Univ Oxford Innovation Ltd Polypeptides and peptide tags capable of spontaneous isopeptide bond formation at low temperature and low pH and uses thereof
US20250163468A1 (en) 2023-11-21 2025-05-22 Regeneron Pharmaceuticals, Inc. Covalently surface modified adeno-associated virus production by in vitro conjugation, and purification of covalently surface modified adeno-associated virus
GB202317925D0 (en) 2023-11-23 2024-01-10 Spybiotech Ltd Vaccines
WO2025135040A1 (ja) * 2023-12-18 2025-06-26 公立大学法人大阪 イソペプチド結合形成による新規ポリペプチドの作製方法
WO2026050618A1 (en) 2024-08-29 2026-03-05 Regeneron Pharmaceuticals, Inc. Polynucleotide constructs and cell lines for recombinant aav production

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530410B2 (en) 1978-02-21 1983-07-14 Sintef Preparing aqueous emulsions
EP2053126A1 (en) * 1998-07-27 2009-04-29 Sanofi Pasteur Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US6936252B2 (en) * 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
DE10108263A1 (de) * 2001-02-21 2002-09-05 Max Planck Gesellschaft Analyse von Modifizierungen und Demodifizierungen von Proteinen mit Ubiquitinverwandten Proteinen mittels FRET (Fluorescence Resonance Energy Transfer)
WO2004031243A1 (ja) * 2002-10-01 2004-04-15 Kumamoto Technology & Industry Foundation タンパク質ポリマー及びその製造方法
EP1989220B1 (en) * 2006-02-02 2011-12-14 Trimeris, Inc. Hiv fusion inhibitor peptides with improved biological properties
CA2688284A1 (en) * 2007-05-25 2008-12-04 Novartis Ag Streptococcus pneumoniae pilus antigens
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20090253131A1 (en) * 2007-11-05 2009-10-08 Promega Corporation Hybrid fusion reporter and uses thereof
GB201002362D0 (en) * 2010-02-11 2010-03-31 Isis Innovation Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
FR2973032A1 (fr) * 2011-03-24 2012-09-28 Commissariat Energie Atomique Peptides aptes a former un complexe covalent et leurs utilisations
US20120259101A1 (en) * 2011-04-11 2012-10-11 Li Tan Isopeptide Bond Formation in Bacillus Species and Uses Thereof
CN105308073B (zh) 2013-06-14 2019-08-13 加利福尼亚太平洋生物科学股份有限公司 双生物素化标签
WO2015156870A2 (en) 2014-01-15 2015-10-15 Massachusetts Institute Of Technology Biopolymer-mediated assembly of nanoparticles using genetically encoded proteins
GB201509782D0 (en) * 2015-06-05 2015-07-22 Isis Innovation Methods and products for fusion protein synthesis

Also Published As

Publication number Publication date
KR20180050640A (ko) 2018-05-15
AU2016272543A1 (en) 2018-01-04
CN108026148B (zh) 2022-12-30
ES2880336T3 (es) 2021-11-24
JP6883529B2 (ja) 2021-06-09
US20180244730A1 (en) 2018-08-30
KR102818627B1 (ko) 2025-06-10
CN108026148A (zh) 2018-05-11
BR112017026042A2 (pt) 2018-08-14
WO2016193746A1 (en) 2016-12-08
CA2987821A1 (en) 2016-12-08
JP2018521640A (ja) 2018-08-09
DK3303374T3 (da) 2021-07-05
US10526379B2 (en) 2020-01-07
CN116199733A (zh) 2023-06-02
EP3303374A1 (en) 2018-04-11
EP3303374B1 (en) 2021-03-31
AU2016272543B2 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
GB201509782D0 (en) Methods and products for fusion protein synthesis
IL254965A0 (en) fusion proteins
ZA201900347B (en) Bispecific proteins and methods for preparing same
GB201509413D0 (en) Fusion protein
ZA201701810B (en) Sirp-alpha immunoglobulin fusion proteins
SG10201913807QA (en) Multivalent and multispecific gitr-binding fusion proteins
GB201509062D0 (en) OX40L fusion proteins and uses thereof
IL247508A0 (en) A method for preparing human plasma proteins
GB201502305D0 (en) Protein
GB201502306D0 (en) Protein
PT3099946T (pt) Meio de fixação e método para fixação de dois componentes
IL246355A0 (en) p97–ids fused proteins
SG10201912410TA (en) Multivalent and multispecific dr5-binding fusion proteins
GB201504691D0 (en) Fusion protein
GB201411943D0 (en) Process and protein product
SG11201606501PA (en) Nanobody-fluorescent protein fusion
GB201501603D0 (en) Method and product
IL258981A (en) Methods for the production of proteins
PL3154360T3 (pl) Produkty mleczne i sposoby ich wytwarzania
GB201503218D0 (en) Particles comprising fusion proteins
EP3237452A4 (en) Fusion proteins and methods thereof
ZA201801394B (en) Fusion protein
GB201712792D0 (en) Fusion protein
GB201602850D0 (en) Fusion proteins
GB201522610D0 (en) Protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)